CEPHODOXIAA CV 200
Item requires a valid prescription
Manufactured By Steris Healthcare Pvt Ltd
Composition Cefpodoxime Proxetil 200 mg And Clavulanate Potassium 125 mg Tablets
Rs 346.50
MRP Rs 495.00
(30% OFF)
Includes all taxes
Package SIZE
( For 10 Tablets )
100% Authentic
Products
Free
Shipping*
Products
Return Policy
Description:
CEPHODOXIAA CV 200 Tablets is a combination antibiotic containing Cefpodoxime Proxetil 200 mg and Clavulanate Potassium 125 mg. It is intended for the management of certain bacterial infections when recommended by a qualified healthcare professional. The formulation pairs the antibacterial properties of Cefpodoxime with the beta-lactamase–inhibiting action of Clavulanate, helping extend coverage against susceptible organisms that produce beta-lactamase enzymes.
This dual-ingredient tablet is considered by physicians for specific bacterial infections involving different body systems when clinical judgment and susceptibility patterns support its use.
Composition
Each tablet contains:
- Cefpodoxime Proxetil IP – 200 mg
- Clavulanate Potassium – 125 mg
Category: Antibiotic combination
Dosage form: Tablets
Brand name: CEPHODOXIAA CV 200
Key Features
- Combines a third-generation cephalosporin (Cefpodoxime Proxetil) with a beta-lactamase inhibitor (Clavulanate Potassium).
- Supports treatment of infections caused by susceptible bacteria.
- May be selected for certain respiratory, urinary, ear-nose-throat, and skin/soft-tissue infections.
- Convenient oral tablet presentation.
- Must be used only under medical supervision.
Potential Uses
CEPHODOXIAA CV 200 may be prescribed for bacterial infections when the causative organisms are susceptible to the combination and the patient’s condition warrants it. Areas where it may be considered include:
- Respiratory tract infections – Selected bacterial bronchitis and other lower or upper respiratory infections.
- Ear, nose, and throat infections – Susceptible bacterial infections in these areas.
- Urinary tract infections – Certain bacterial UTIs when organism susceptibility is confirmed or reasonably expected.
- Skin and soft-tissue infections – Bacterial infections involving the skin and underlying tissues.
- Other susceptible bacterial infections – As determined by clinical assessment and laboratory findings.
Important: This product is an antibiotic and has no activity against viruses (e.g., common cold or influenza).
Mechanism of Action
The two active ingredients act in complementary ways:
- Cefpodoxime Proxetil is a third-generation cephalosporin that disrupts bacterial cell-wall synthesis, impairing bacterial growth and survival.
- Clavulanate Potassium inhibits beta-lactamase enzymes produced by some bacteria. These enzymes can degrade certain beta-lactam antibiotics; by blocking them, Clavulanate helps preserve the activity of Cefpodoxime.
Together they provide broader antibacterial coverage against susceptible organisms than the cephalosporin alone in many cases.
Formulation Advantages
- Single-tablet dual-action formulation.
- Complementary mechanisms (cell-wall inhibition + beta-lactamase protection).
- Oral dosage form suitable for outpatient or prescribed outpatient use when appropriate.
- Allows physicians to choose a combination antibiotic matched to the infection and patient factors.
Dosage and Administration
Dose, frequency, and duration must be determined by a physician according to the infection type and severity, patient age, renal function, and overall clinical status. Patients should take the tablets exactly as prescribed, complete the full course, and never adjust the dose or share the medicine without medical advice.
Possible Side Effects
As with other antibiotics, some individuals may experience:
- Nausea
- Vomiting
- Diarrhoea
- Abdominal discomfort
- Headache
- Skin rash
Persistent or severe symptoms should be reported to a healthcare professional. Immediate medical attention is required for signs of serious allergic reaction (difficulty breathing, facial swelling, severe skin reactions, etc.).
Precautions and Warnings
Inform the prescribing doctor of any relevant history, particularly:
- Allergy to cephalosporins, penicillins, or other beta-lactam antibiotics
- Kidney impairment
- Previous antibiotic-associated diarrhoea
- Pregnancy or breastfeeding
Use only when prescribed. Avoid self-medication and unnecessary antibiotic exposure, which can promote antimicrobial resistance.
Storage
- Store in a cool, dry place.
- Protect from direct sunlight and excess moisture.
- Keep out of reach of children.
- Follow the storage directions on the pack.
- Do not use after the expiry date.
Conclusion
CEPHODOXIAA CV 200 Tablets (Cefpodoxime Proxetil 200 mg + Clavulanate Potassium 125 mg) is a combination antibiotic designed to deliver complementary antibacterial activity against susceptible bacteria. When clinically appropriate, it may be chosen by healthcare professionals for selected bacterial infections. Always use it strictly according to medical advice, complete the prescribed course, and never self-medicate.
Frequently Asked Questions
Q1. What is CEPHODOXIAA CV 200 used for?
It is a combination antibiotic that may be prescribed for certain bacterial infections of the respiratory tract, urinary tract, ear-nose-throat region, and skin/soft tissues, among others, when the bacteria are susceptible.
Q2. What are the active ingredients?
Each tablet contains Cefpodoxime Proxetil 200 mg and Clavulanate Potassium 125 mg.
Q3. How does it work?
Cefpodoxime interferes with bacterial cell-wall formation; Clavulanate inhibits beta-lactamase enzymes that would otherwise inactivate the antibiotic.
Q4. Does it treat viral infections?
No. It is effective only against susceptible bacteria and has no activity against viruses such as those causing colds or flu.
Q5. Can it be taken without a prescription?
No. It must be used only under the direction and prescription of a qualified healthcare professional.